Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis
A. J. Lesse
, Carol Freer
, R. A. Salata
, J. B. Francis
, W. M. Scheld
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Osteomyelitis
100%
Gram-negative
100%
Ciprofloxacin
100%
Bacillary
100%
Gram-negative Bacilli
66%
Minimum Inhibitory Concentration
33%
Geometric Mean
33%
Chronic Disease
16%
Gram-positive Cocci
16%
Ankle
16%
Twice Daily
16%
In Vitro Activity
16%
Liver Function Tests
16%
Nausea
16%
Gram-positive
16%
Methicillin-resistant Staphylococcus Aureus
16%
Pseudomonas Species
16%
Superinfection
16%
Tibia
16%
Phalanx
16%
Metatarsal
16%
Outpatient Treatment
16%
Lethargy
16%
Vertebrae
16%
Acute Disease
16%
Gram-negative Rods
16%
Conventional Therapy
16%
Percutaneous Biopsy
16%
Bone Culture
16%
Open Biopsy
16%
Outpatient Therapy
16%
Urticaria
16%
Renal Function Tests
16%
Medicine and Dentistry
Osteomyelitis
100%
Ciprofloxacin
100%
Gram-Negative Bacteria
83%
Outpatient
33%
Pathogen
16%
In Vitro
16%
Infection
16%
Side Effect
16%
Gram Positive Cocci
16%
Pseudomonas
16%
Chronic Disease
16%
Liver Function Test
16%
Methicillin Resistant Staphylococcus Aureus
16%
Urticaria
16%
Superinfection
16%
Tibia
16%
Nausea
16%
Vertebra
16%
Acute Disease
16%
Phalanx
16%
Percutaneous Biopsy
16%
Open Biopsy
16%
Kidney Function Test
16%